U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 129

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr6:47541979
GRCh38:
Chr6:47574243
CD2APP241TFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Dec 23, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr6:47470996
GRCh38:
Chr6:47503260
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr6:47576851
GRCh38:
Chr6:47609115
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Aug 21, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr6:47567019-47567020
GRCh38:
Chr6:47599283-47599284
CD2APFocal segmental glomerulosclerosis 3, susceptibility to, not providedBenign/Likely benign
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr6:47577038
GRCh38:
Chr6:47609302
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Jun 3, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr6:47501483
GRCh38:
Chr6:47533747
CD2API104NFocal segmental glomerulosclerosis 3, susceptibility to, not providedUncertain significance
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr6:47541809
GRCh38:
Chr6:47574073
CD2APL184SFocal segmental glomerulosclerosis 3, susceptibility to, not providedUncertain significance
(Apr 21, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr6:47576982
GRCh38:
Chr6:47609246
CD2APL586Fnot provided, Focal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Nov 27, 2021)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr6:47576960-47576961
GRCh38:
Chr6:47609224-47609225
CD2APN581fsFocal segmental glomerulosclerosis 3, susceptibility toPathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr6:47501422
GRCh38:
Chr6:47533686
CD2APR84*Focal segmental glomerulosclerosis 3, susceptibility toPathogenic
(Jul 3, 2021)
criteria provided, single submitter
11.
GRCh37:
Chr6:47541894
GRCh38:
Chr6:47574158
CD2APFocal segmental glomerulosclerosis 3, susceptibility to, not providedBenign/Likely benign
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr6:47522408
GRCh38:
Chr6:47554672
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr6:47501347-47501348
GRCh38:
Chr6:47533611-47533612
CD2APE60fsFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jul 12, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr6:47573971
GRCh38:
Chr6:47606235
CD2APM496Inot provided, Focal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr6:47522482
GRCh38:
Chr6:47554746
CD2APH174Pnot provided, Focal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr6:47471037
GRCh38:
Chr6:47503301
CD2APD9Gnot provided, Focal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(May 5, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr6:47544293-47544294
GRCh38:
Chr6:47576557-47576558
CD2APS256fsnot provided, Focal segmental glomerulosclerosis 3, susceptibility toPathogenic/Likely pathogenic
(May 12, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr6:47594080
GRCh38:
Chr6:47626344
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
19.
GRCh37:
Chr6:47593881
GRCh38:
Chr6:47626145
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr6:47591964
GRCh38:
Chr6:47624228
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr6:47575726
GRCh38:
Chr6:47607990
CD2APP532SFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr6:47522413
GRCh38:
Chr6:47554677
CD2APN151SInborn genetic diseases, Focal segmental glomerulosclerosis 3, susceptibility toConflicting interpretations of pathogenicity
(May 9, 2023)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr6:47501393
GRCh38:
Chr6:47533657
CD2APR74MFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Mar 3, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr6:47501354
GRCh38:
Chr6:47533618
CD2APT61MFocal segmental glomerulosclerosis 3, susceptibility to, not provided, Inborn genetic diseases
Uncertain significance
(Nov 10, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr6:47471189
GRCh38:
Chr6:47503453
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(Aug 11, 2021)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr6:47592980
GRCh38:
Chr6:47625244
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr6:47592725
GRCh38:
Chr6:47624989
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr6:47592669
GRCh38:
Chr6:47624933
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
29.
GRCh37:
Chr6:47574025
GRCh38:
Chr6:47606289
CD2APFocal segmental glomerulosclerosis 3, susceptibility to, not providedBenign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr6:47563652
GRCh38:
Chr6:47595916
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr6:47445912
GRCh38:
Chr6:47478176
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr6:47445815
GRCh38:
Chr6:47478079
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
33.
GRCh37:
Chr6:47594511
GRCh38:
Chr6:47626775
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
34.
GRCh37:
Chr6:47594433
GRCh38:
Chr6:47626697
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
35.
GRCh37:
Chr6:47592512
GRCh38:
Chr6:47624776
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
36.
GRCh37:
Chr6:47592467
GRCh38:
Chr6:47624731
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr6:47563636
GRCh38:
Chr6:47595900
CD2APA383EFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr6:47544782
GRCh38:
Chr6:47577046
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
39.
GRCh37:
Chr6:47544287
GRCh38:
Chr6:47576551
CD2APK253EFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
40.
GRCh37:
Chr6:47594357
GRCh38:
Chr6:47626621
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr6:47594284
GRCh38:
Chr6:47626548
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr6:47594272
GRCh38:
Chr6:47626536
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr6:47592289
GRCh38:
Chr6:47624553
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 15, 2018)
criteria provided, single submitter
44.
GRCh37:
Chr6:47592260
GRCh38:
Chr6:47624524
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr6:47592129
GRCh38:
Chr6:47624393
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr6:47592123
GRCh38:
Chr6:47624387
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 12, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr6:47544253
GRCh38:
Chr6:47576517
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr6:47541933
GRCh38:
Chr6:47574197
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
49.
GRCh37:
Chr6:47541789
GRCh38:
Chr6:47574053
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
50.
GRCh37:
Chr6:47544260
GRCh38:
Chr6:47576524
CD2APP244Snot provided, Focal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr6:47541928
GRCh38:
Chr6:47574192
CD2APS224PFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Oct 28, 2019)
no assertion criteria provided
52.
GRCh37:
Chr6:47548626
GRCh38:
Chr6:47580890
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr6:47471053
GRCh38:
Chr6:47503317
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr6:47576867
GRCh38:
Chr6:47609131
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Oct 12, 2021)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr6:47576922
GRCh38:
Chr6:47609186
CD2APP566Snot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(May 9, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr6:47548605
GRCh38:
Chr6:47580869
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(May 8, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr6:47573999
GRCh38:
Chr6:47606263
CD2APN506DFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 10, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr6:47567141
GRCh38:
Chr6:47599405
CD2APD460fsFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Nov 22, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr6:47548637
GRCh38:
Chr6:47580901
CD2APFocal segmental glomerulosclerosis 3, susceptibility toPathogenic
(Oct 16, 2017)
no assertion criteria provided
60.
GRCh37:
Chr6:47544838
GRCh38:
Chr6:47577102
CD2APK301MFocal segmental glomerulosclerosis 3, susceptibility to, not provided, not specified
Uncertain significance
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr6:47594722
GRCh38:
Chr6:47626986
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
62.
GRCh37:
Chr6:47594668
GRCh38:
Chr6:47626932
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr6:47594412
GRCh38:
Chr6:47626676
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr6:47594408
GRCh38:
Chr6:47626672
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr6:47594332
GRCh38:
Chr6:47626596
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr6:47594318
GRCh38:
Chr6:47626582
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 12, 2018)
criteria provided, single submitter
67.
GRCh37:
Chr6:47594302
GRCh38:
Chr6:47626566
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 12, 2018)
criteria provided, single submitter
68.
GRCh37:
Chr6:47594204
GRCh38:
Chr6:47626468
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
69.
GRCh37:
Chr6:47594195
GRCh38:
Chr6:47626459
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
70.
GRCh37:
Chr6:47594081
GRCh38:
Chr6:47626345
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
71.
GRCh37:
Chr6:47594002
GRCh38:
Chr6:47626266
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr6:47594000
GRCh38:
Chr6:47626264
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr6:47593890
GRCh38:
Chr6:47626154
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
74.
GRCh37:
Chr6:47593569
GRCh38:
Chr6:47625833
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
75.
GRCh37:
Chr6:47593171
GRCh38:
Chr6:47625435
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
76.
GRCh37:
Chr6:47592829
GRCh38:
Chr6:47625093
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr6:47592791
GRCh38:
Chr6:47625055
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
78.
GRCh37:
Chr6:47592670
GRCh38:
Chr6:47624934
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr6:47592615
GRCh38:
Chr6:47624879
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
80.
GRCh37:
Chr6:47592465
GRCh38:
Chr6:47624729
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
81.
GRCh37:
Chr6:47592463
GRCh38:
Chr6:47624727
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
82.
GRCh37:
Chr6:47592461
GRCh38:
Chr6:47624725
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr6:47592459
GRCh38:
Chr6:47624723
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
84.
GRCh37:
Chr6:47592457
GRCh38:
Chr6:47624721
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
85.
GRCh37:
Chr6:47592455
GRCh38:
Chr6:47624719
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
86.
GRCh37:
Chr6:47592415
GRCh38:
Chr6:47624679
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
87.
GRCh37:
Chr6:47592282
GRCh38:
Chr6:47624546
CD2APFocal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
88.
GRCh37:
Chr6:47592149
GRCh38:
Chr6:47624413
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr6:47591983
GRCh38:
Chr6:47624247
CD2APFocal segmental glomerulosclerosis 3, susceptibility toBenign
(Jan 13, 2018)
criteria provided, single submitter
90.
GRCh37:
Chr6:47576899
GRCh38:
Chr6:47609163
CD2APA558Vnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr6:47576877
GRCh38:
Chr6:47609141
CD2APT551AFocal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Jan 13, 2018)
criteria provided, single submitter
92.
GRCh37:
Chr6:47576853
GRCh38:
Chr6:47609117
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toUncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr6:47575700-47575702
GRCh38:
Chr6:47607964-47607966
CD2APE525delnot provided, Focal segmental glomerulosclerosisUncertain significance
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr6:47575648
GRCh38:
Chr6:47607912
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr6:47567166
GRCh38:
Chr6:47599430
CD2APFocal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Jan 13, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr6:47563676
GRCh38:
Chr6:47595940
CD2APnot provided, Focal segmental glomerulosclerosis 3, susceptibility toLikely benign
(Feb 9, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr6:47563669
GRCh38:
Chr6:47595933
CD2APP394Qnot provided, Focal segmental glomerulosclerosis 3, susceptibility toBenign/Likely benign
(Jul 29, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr6:47547209
GRCh38:
Chr6:47579473
CD2APL331Hnot provided, Focal segmental glomerulosclerosis 3, susceptibility toConflicting interpretations of pathogenicity
(Sep 10, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr6:47541940
GRCh38:
Chr6:47574204
CD2APR228Wnot provided, Focal segmental glomerulosclerosis 3, susceptibility toConflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
100.
GRCh37:
Chr6:47541811
GRCh38:
Chr6:47574075
CD2APA185Snot provided, Focal segmental glomerulosclerosis 3, susceptibility toConflicting interpretations of pathogenicity
(Oct 23, 2022)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination